RBMX and cancer: We did not identify any RBP which uniquely target either the exosomal or the cellular lncRNAs, however there is a significant difference in the number of binding sites for RBMX, ELAVL1 and SFRS1 in the exosomal lncRNAs compared to cellular lncRNAs of both healthy and cancer cell lines.